financetom
Market
financetom
/
Market
/
SEC official warns SPACs have “significant, undiscovered” issues
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
SEC official warns SPACs have “significant, undiscovered” issues
Apr 8, 2021 6:11 AM

John Coates, a top official from the US Securities and Exchange Commission (SEC), has warned that the Special Purpose Acquisition Companies (SPACs) have some “significant and yet undiscovered” issues.

Share Market Live

NSE

SPAC listings bypass some safeguards that traditional IPOs offer which they make up for by offering big rewards.

These issues are not going to stop them by any means, said Coates, the director of the SEC’s Corporate Finance division. But, “They are relatively as yet incompletely worked through mechanisms, despite the fact they have been around for a while,” he said.

SPACs have raised nearly $100 billion YTD, with over 300 listed blank-check firms.

SPACs, or blank-check firms, are shell corporations designed to take companies public without taking the traditional IPO route. A listed SPAC targets and merges with a private firm, and takes it public.

Being recessive after the global financial crisis, SPACs became a red-hot investment asset in 2020. From celebrities to hedge funds, nearly 250 companies raised over $80 billion in the US in 2020. Several analysts had slated this precipitous surge in interest to speculation.

The rally cooled down in the beginning of March. The SPAC index has fallen over 20 percent from its February high. However, it could not escape the regulator’s eye.

Late in March, SEC commenced an inquiry into the SPAC frenzy. The regulator was seeking information on how underwriters manage the risks involved.

Coates said Wednesday that the agency is to issue more comments about the market in the coming weeks.

The regulator’s focus on SPACs is expected to increase now that the administration has changed. While Trump favoured all forms of public offerings, Democrats are expected to scrutinize deals closely.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ProShares UltraPro QQQ (TQQQ) Surges As Rate Cut Hopes Return: Here's What's Going On
ProShares UltraPro QQQ (TQQQ) Surges As Rate Cut Hopes Return: Here's What's Going On
Nov 24, 2025
Shares of ProShares UltraPro QQQ ( TQQQ ) are trading higher Monday morning as traders pile back into leveraged bets on the Nasdaq-100 as fresh macro and historical signals favor growth stocks. Here’s what investors need to know. TQQQ is showing exceptional strength. Check the full analysis here. What To Know: TQQQ is a 3x-leveraged exchange-traded fund designed to deliver...
US STOCKS-S&P 500, Nasdaq gain as traders bet on December Fed rate cut
US STOCKS-S&P 500, Nasdaq gain as traders bet on December Fed rate cut
Nov 24, 2025
* Indexes up: Dow 0.01%, S&P 500 0.72%, Nasdaq up 1.49% * Deutsche Bank sees S&P 500 rising to 8,000 by 2026 end * Bristol Myers gains after rivals positive late-stage data (Updates with opening prices) By Johann M Cherian and Pranav Kashyap Nov 24 (Reuters) - The S&P 500 and the Nasdaq rose on Monday, led by mega-cap stocks,...
US STOCKS-Wall Street surges on tech rally, rate cut optimism
US STOCKS-Wall Street surges on tech rally, rate cut optimism
Nov 24, 2025
* Indexes up: Dow 0.54%, S&P 500 1.33%, Nasdaq up 2.36% * Deutsche Bank sees S&P 500 rising to 8,000 by 2026 end * Bristol Myers gains after rivals positive late-stage data (Updates to mid-session trading) By Johann M Cherian and Pranav Kashyap Nov 24 (Reuters) - Wall Street's main indexes rose on Monday, on the back of gains from...
Top Midday Stories: Novo Nordisk Drug Fails to Meet Primary Endpoint in Alzheimer's Study; Trump Considering Letting Nvidia Sell Advanced Chips to China
Top Midday Stories: Novo Nordisk Drug Fails to Meet Primary Endpoint in Alzheimer's Study; Trump Considering Letting Nvidia Sell Advanced Chips to China
Nov 24, 2025
11:37 AM EST, 11/24/2025 (MT Newswires) -- All three major US stock indexes were up in late-morning trading on Monday, as the stock market looks to rebound from a down session the week prior. In company news, Novo Nordisk ( NVO ) said Monday its weight-loss drug semaglutide failed to meet its primary endpoint of reducing Alzheimer's progression in two...
Copyright 2023-2026 - www.financetom.com All Rights Reserved